NRG GY003 Temporary Closure


NRG-GY003
has met its first stage accrual goal and is temporarily closed to patient entry effective October 7, 2015. A decision about re-opening this study will be made when analysis of the first stage patients has been completed.
Documents are posted on the NRG Oncology website.



View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center, 1600 JFK Blvd., Suite1020, Philadelphia, PA, 19103


Unsubscribe
Text block at your service. Replace this text with yours.